TECH
Price
$75.83
Change
-$0.27 (-0.35%)
Updated
Jan 17 closing price
Capitalization
12.05B
17 days until earnings call
VRTX
Price
$422.00
Change
+$5.04 (+1.21%)
Updated
Jan 17 closing price
Capitalization
108.68B
24 days until earnings call
Ad is loading...

TECH vs VRTX

Header iconTECH vs VRTX Comparison
Open Charts TECH vs VRTXBanner chart's image
Bio-Techne
Price$75.83
Change-$0.27 (-0.35%)
Volume$990.97K
Capitalization12.05B
Vertex Pharmaceuticals
Price$422.00
Change+$5.04 (+1.21%)
Volume$1.77M
Capitalization108.68B
TECH vs VRTX Comparison Chart
Loading...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TECH vs. VRTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TECH is a Hold and VRTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (TECH: $75.83 vs. VRTX: $422.00)
Brand notoriety: TECH and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TECH: 109% vs. VRTX: 102%
Market capitalization -- TECH: $12.05B vs. VRTX: $108.68B
TECH [@Biotechnology] is valued at $12.05B. VRTX’s [@Biotechnology] market capitalization is $108.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TECH’s FA Score shows that 2 FA rating(s) are green whileVRTX’s FA Score has 1 green FA rating(s).

  • TECH’s FA Score: 2 green, 3 red.
  • VRTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TECH is a better buy in the long-term than VRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TECH’s TA Score shows that 5 TA indicator(s) are bullish while VRTX’s TA Score has 4 bullish TA indicator(s).

  • TECH’s TA Score: 5 bullish, 3 bearish.
  • VRTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both TECH and VRTX are a good buy in the short-term.

Price Growth

TECH (@Biotechnology) experienced а +3.44% price change this week, while VRTX (@Biotechnology) price change was +3.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

TECH is expected to report earnings on Apr 30, 2025.

VRTX is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($109B) has a higher market cap than TECH($12B). TECH has higher P/E ratio than VRTX: TECH (79.82) vs VRTX (32.76). TECH YTD gains are higher at: 5.276 vs. VRTX (4.793). VRTX has higher annual earnings (EBITDA): 518M vs. TECH (301M). VRTX has more cash in the bank: 6.52B vs. TECH (188M). TECH has less debt than VRTX: TECH (399M) vs VRTX (1.7B). VRTX has higher revenues than TECH: VRTX (10.6B) vs TECH (1.17B).
TECHVRTXTECH / VRTX
Capitalization12B109B11%
EBITDA301M518M58%
Gain YTD5.2764.793110%
P/E Ratio79.8232.76244%
Revenue1.17B10.6B11%
Total Cash188M6.52B3%
Total Debt399M1.7B23%
FUNDAMENTALS RATINGS
TECH vs VRTX: Fundamental Ratings
TECH
VRTX
OUTLOOK RATING
1..100
1219
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
77
Overvalued
PROFIT vs RISK RATING
1..100
6918
SMR RATING
1..100
7890
PRICE GROWTH RATING
1..100
4963
P/E GROWTH RATING
1..100
1536
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (3) in the Biotechnology industry is significantly better than the same rating for VRTX (77). This means that TECH’s stock grew significantly faster than VRTX’s over the last 12 months.

VRTX's Profit vs Risk Rating (18) in the Biotechnology industry is somewhat better than the same rating for TECH (69). This means that VRTX’s stock grew somewhat faster than TECH’s over the last 12 months.

TECH's SMR Rating (78) in the Biotechnology industry is in the same range as VRTX (90). This means that TECH’s stock grew similarly to VRTX’s over the last 12 months.

TECH's Price Growth Rating (49) in the Biotechnology industry is in the same range as VRTX (63). This means that TECH’s stock grew similarly to VRTX’s over the last 12 months.

TECH's P/E Growth Rating (15) in the Biotechnology industry is in the same range as VRTX (36). This means that TECH’s stock grew similarly to VRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TECHVRTX
RSI
ODDS (%)
N/A
Bullish Trend 11 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
63%
Bearish Trend 11 days ago
66%
Momentum
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
63%
MACD
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
70%
Bullish Trend 11 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
67%
Bearish Trend 11 days ago
43%
Advances
ODDS (%)
Bullish Trend 11 days ago
71%
Bullish Trend 11 days ago
61%
Declines
ODDS (%)
Bearish Trend 17 days ago
72%
Bearish Trend 20 days ago
44%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 11 days ago
60%
Bearish Trend 11 days ago
37%
View a ticker or compare two or three
Ad is loading...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
ENS.X36.1291803.010399
+9.09%
Ethereum Name Service cryptocurrency
GMX.X26.6039142.037283
+8.29%
GMX cryptocurrency
NAIL97.990.96
+0.99%
Direxion Daily Hmbldrs&Supls Bull 3X ETF
UNOV34.960.10
+0.28%
Innovator US Equity Ultra Buffer ETF Nov
PUTD20.930.01
+0.05%
Cboe(R) Validus S&P 500(R) Dyn PtwIdxETF

VRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with CCCC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
+1.21%
CCCC - VRTX
39%
Loosely correlated
+2.07%
REGN - VRTX
37%
Loosely correlated
-1.68%
STTK - VRTX
37%
Loosely correlated
+1.83%
GMAB - VRTX
35%
Loosely correlated
-1.98%
TECH - VRTX
34%
Loosely correlated
-0.35%
More